[Calculation of the degree of secretory activity of the endocrine organs]

Two Key Substitutions in the Chromophore Environment of mKate2 Produce an Enhanced FusionRed-like Red Fluorescent Protein.

Acta naturae·2025

Molecular Tools for Targeted Control of Nerve Cell Electrical Activity. Part II.

Acta naturae·2022

Molecular Tools for Targeted Control of Nerve Cell Electrical Activity. Part I.

Acta naturae·2021

Molecular Principles of Insect Chemoreception.

Acta naturae·2020

Synthetic sialylglycopolymer receptor for virus detection using cantilever-based sensors.

The Analyst·2015

[Study of the interaction between antigen-antibody complexes for label-free sensor application].

Biomeditsinskaia khimiia·2013

[The results of a comparative study of different series of commercial casein-carbon agar].

Laboratornoe delo·1991

[New selective agents for the isolation of Pseudomonas aeruginosa].

Laboratornoe delo·1991

[A method of rapid indication of an antigen].

Laboratornoe delo·1991

[Serotypes of Pseudomonas aeruginosa strains isolated in obstetric institutions in Azerbaijan].

Laboratornoe delo·1991

[A method of indirect immunofluorescence for diagnosing chlamydia infections].

Laboratornoe delo·1991

[A highly sensitive immunoenzyme analysis using electrochemical detection].

Laboratornoe delo·1991

CSK-DDI: Compensating Structural Incompleteness with Knowledge Graph World Knowledge for Drug-Drug Interaction Modeling.

Bioinformatics (Oxford, England)·2026

Evaluation of capsid inhibitor resistance profiles and HIV-1 subtype distribution via near-full-length genome NGS in ART-naive HIV-1 patients in Guangxi, China.

The Journal of antimicrobial chemotherapy·2026

Antihypertensive drug-induced liver injury is rare, but strongly associated with HLA-B∗35:01.

Acta pharmaceutica Sinica. B·2026

Erratum: Author correction to "Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR" [Acta Pharm Sin B 12 (2022) 1339-1350].

Acta pharmaceutica Sinica. B·2026

Discovery of a potent covalent inhibitor for the treatment of sepsis targeting DNAJC9: Identification of a druggable target for inflammation.

Acta pharmaceutica Sinica. B·2026

Identification and characterization of a non-nucleotide RdRp allosteric inhibitor with pan-coronavirus protection.

Acta pharmaceutica Sinica. B·2026

Related Experiment Videos

[Calculation of the degree of secretory activity of the endocrine organs]

Related Concept Videos

Two Key Substitutions in the Chromophore Environment of mKate2 Produce an Enhanced FusionRed-like Red Fluorescent Protein.

Molecular Tools for Targeted Control of Nerve Cell Electrical Activity. Part II.

Molecular Tools for Targeted Control of Nerve Cell Electrical Activity. Part I.

Molecular Principles of Insect Chemoreception.

Synthetic sialylglycopolymer receptor for virus detection using cantilever-based sensors.

[Study of the interaction between antigen-antibody complexes for label-free sensor application].

[The results of a comparative study of different series of commercial casein-carbon agar].

[New selective agents for the isolation of Pseudomonas aeruginosa].

[A method of rapid indication of an antigen].

[Serotypes of Pseudomonas aeruginosa strains isolated in obstetric institutions in Azerbaijan].

[A method of indirect immunofluorescence for diagnosing chlamydia infections].

[A highly sensitive immunoenzyme analysis using electrochemical detection].

CSK-DDI: Compensating Structural Incompleteness with Knowledge Graph World Knowledge for Drug-Drug Interaction Modeling.

Evaluation of capsid inhibitor resistance profiles and HIV-1 subtype distribution via near-full-length genome NGS in ART-naive HIV-1 patients in Guangxi, China.

Antihypertensive drug-induced liver injury is rare, but strongly associated with HLA-B∗35:01.

Erratum: Author correction to "Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR" [Acta Pharm Sin B 12 (2022) 1339-1350].

Discovery of a potent covalent inhibitor for the treatment of sepsis targeting DNAJC9: Identification of a druggable target for inflammation.

Identification and characterization of a non-nucleotide RdRp allosteric inhibitor with pan-coronavirus protection.

Related Experiment Videos

[Calculation of the degree of secretory activity of the endocrine organs]

Related Concept Videos

Related Articles